ACTRN12616000081415已完成未知
Travel for trials: Examining cancer patients’ willingness to travel to participate in a clinical trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 192
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Diagnosis of cancer
- •English language sufficient for completion of questionnaire
- •Attending a cancer clinic for management of cancer
排除标准
- •Previous completion of this questionnaire.
研究者
相似试验
进行中（未招募）
Unknown
A study comparing cancer patients randomly assigned to be offered either genetic testing ‘at home’ or in hospitalPatients diagnosed with colorectal, endometrial, or ovarian cancer eligible for genetic testing for cancer susceptibility gene variantsCancerISRCTN57402067Queen Mary University of London832
已完成
不适用
Cancer Research Campaign trial for the treatment of women with early breast cancer: the role of local prophylactic radiotherapyBreastCancerISRCTN65764657Cancer Research UK (CRUK) (UK)
已完成
不适用
utritional therapy for cancer patientCTRI/2021/03/031634Rajiv Gandhi university of Health Sciences Grant in aid for advanced research project100
已完成
Unknown
A clinical trial in patients with malignancies where the spaces formed by the KHKA-01 are needed in performing particle radiation therapy.Patients with intraperitoneal or intrapelvic malignancies where the adjacent digestive tract made it difficult to perform particle radiation therapy and the spaces are required between malignancies and the digestive tract in the absence of effective therapies other than particle radiation therapy.JPRN-jRCT1092220318Alfresa Pharma Corporation5
进行中（未招募）
1 期
A Cancer Research UK randomised phase II trial of ATN-224 (copper binding agent) in combination with exemestane versus exemestane alone in post-menopausal women with recurrent or advanced, oestrogen and/or progesterone receptor positive breast cancerrecurrent or advanced oestrogen and/or progesterone receptor positive breast cancerMedDRA version: 9.1 Level: LLT Classification code 10006198 Term: Breast cancer recurrentEUCTR2007-005752-16-GBCancer Research UK111